Nils Brünner

4.2k total citations
96 papers, 2.4k citations indexed

About

Nils Brünner is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Nils Brünner has authored 96 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 65 papers in Oncology, 43 papers in Molecular Biology and 40 papers in Cancer Research. Recurrent topics in Nils Brünner's work include Protease and Inhibitor Mechanisms (23 papers), Peptidase Inhibition and Analysis (19 papers) and Colorectal Cancer Treatments and Studies (19 papers). Nils Brünner is often cited by papers focused on Protease and Inhibitor Mechanisms (23 papers), Peptidase Inhibition and Analysis (19 papers) and Colorectal Cancer Treatments and Studies (19 papers). Nils Brünner collaborates with scholars based in Denmark, Sweden and United States. Nils Brünner's co-authors include Ib Jarle Christensen, Hans Jørgen Nielsen, Jan Stenvang, Henning T. Mouridsen, Birgitte Nauntofte, Jesper Reibel, Siri Beier Jensen, Robert Clarke, Adam Baker and Anne‐Sofie Schrohl and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and American Journal of Clinical Nutrition.

In The Last Decade

Nils Brünner

96 papers receiving 2.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nils Brünner Denmark 29 1.2k 1.0k 972 322 226 96 2.4k
Erzsébet Rásó Hungary 29 1.1k 0.9× 840 0.8× 501 0.5× 409 1.3× 220 1.0× 90 2.2k
Ruth Birbe United States 29 1.5k 1.3× 707 0.7× 1.1k 1.2× 427 1.3× 248 1.1× 50 2.7k
Zhi-Ming Shao China 32 2.1k 1.7× 1.2k 1.2× 1.3k 1.3× 467 1.5× 447 2.0× 60 3.6k
Sudha K. Pai United States 20 2.1k 1.7× 916 0.9× 945 1.0× 389 1.2× 226 1.0× 31 2.9k
Arja Jukkola‐Vuorinen Finland 25 898 0.7× 1.0k 1.0× 800 0.8× 341 1.1× 369 1.6× 51 2.2k
Yunus A. Luqmani Kuwait 25 1.2k 1.0× 941 0.9× 606 0.6× 265 0.8× 184 0.8× 66 2.5k
Xuanmao Jiao United States 30 1.8k 1.5× 1.3k 1.3× 655 0.7× 251 0.8× 540 2.4× 58 3.0k
Misako Watabe United States 24 2.4k 2.0× 1.1k 1.1× 1.1k 1.1× 444 1.4× 245 1.1× 42 3.4k
Bei Lin China 28 1.7k 1.4× 621 0.6× 728 0.7× 300 0.9× 593 2.6× 156 2.8k
Stephanie Curran United Kingdom 20 1.2k 1.0× 1.3k 1.2× 1.2k 1.2× 273 0.8× 143 0.6× 28 2.7k

Countries citing papers authored by Nils Brünner

Since Specialization
Citations

This map shows the geographic impact of Nils Brünner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nils Brünner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nils Brünner more than expected).

Fields of papers citing papers by Nils Brünner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nils Brünner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nils Brünner. The network helps show where Nils Brünner may publish in the future.

Co-authorship network of co-authors of Nils Brünner

This figure shows the co-authorship network connecting the top 25 collaborators of Nils Brünner. A scholar is included among the top collaborators of Nils Brünner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nils Brünner. Nils Brünner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Noer, Julie B., Sune Boris Nygård, Ulrik Lademann, et al.. (2023). The invariant chain CD74 protein is a cell surface binding partner of TIMP‐1 in breast cancer cells. Molecular Oncology. 17(8). 1595–1612. 5 indexed citations
3.
Espinoza, Jaime A., Richa Batra, Elena Papaleo, et al.. (2016). Cytokine profiling of tumor interstitial fluid of the breast and its relationship with lymphocyte infiltration and clinicopathological characteristics. OncoImmunology. 5(12). e1248015–e1248015. 42 indexed citations
4.
Nygård, Sune Boris, Ben Vainer, Fred T. Bosman, et al.. (2015). DNA Topoisomerase I Gene Copy Number and mRNA Expression Assessed as Predictive Biomarkers for Adjuvant Irinotecan in Stage II/III Colon Cancer. Clinical Cancer Research. 22(7). 1621–1631. 12 indexed citations
5.
Nygård, Sune Boris, Tim Svenstrup Poulsen, Dorte Linnemann, et al.. (2015). Topoisomerase‐1 and ‐2A gene copy numbers are elevated in mismatch repair‐proficient colorectal cancers. Molecular Oncology. 9(6). 1207–1217. 21 indexed citations
6.
Smith, David H, Anne‐Marie Kanstrup Fiehn, Ib Jarle Christensen, et al.. (2014). Measuring ERCC1 protein expression in cancer specimens: Validation of a novel antibody. Scientific Reports. 4(1). 4313–4313. 16 indexed citations
7.
Guil‐Luna, Silvia, et al.. (2014). Progesterone receptor isoform A may regulate the effects of neoadjuvant aglepristone in canine mammary carcinoma. BMC Veterinary Research. 10(1). 296–296. 9 indexed citations
8.
Nygård, Sune Boris, et al.. (2013). Assessment of the topoisomerase I gene copy number as a predictive biomarker of objective response to irinotecan in metastatic colorectal cancer. Scandinavian Journal of Gastroenterology. 49(1). 84–91. 15 indexed citations
9.
Holten-Andersen, Lars, Morten Thaysen‐Andersen, Siri Beier Jensen, et al.. (2011). Salivary tissue inhibitor of metalloproteinases-1 localization and glycosylation profile analysis. Apmis. 119(11). 741–749. 7 indexed citations
11.
Nielsen, Hans Jørgen, Ib Jarle Christensen, & Nils Brünner. (2010). A novel prognostic index in colorectal cancer defined by serum carcinoembryonic antigen and plasma tissue inhibitor of metalloproteinases-1. Scandinavian Journal of Gastroenterology. 45(2). 200–207. 13 indexed citations
13.
14.
Sieuwerts, Anieta M., Pernille A. Usher, Marion E. Meijer‐van Gelder, et al.. (2007). Concentrations of TIMP1 mRNA Splice Variants and TIMP-1 Protein Are Differentially Associated with Prognosis in Primary Breast Cancer. Clinical Chemistry. 53(7). 1280–1288. 31 indexed citations
15.
Johansen, Julia S., Ib Jarle Christensen, Rikke Riisbro, et al.. (2003). High Serum YKL-40 Levels in Patients with Primary Breast Cancer is Related to Short Recurrence Free Survival. Breast Cancer Research and Treatment. 80(1). 15–21. 111 indexed citations
16.
Clarke, Robert & Nils Brünner. (1996). Acquired estrogen independence and antiestrogen resistance in breast cancer. Trends in Endocrinology and Metabolism. 7(8). 291–301. 34 indexed citations
17.
Pappot, Helle & Nils Brünner. (1995). The plasminogen activation system and its role in lung cancer. A review. Lung Cancer. 12(1-2). 1–12. 14 indexed citations
19.
Brünner, Nils, C. Kent Osborne, & Mogens Spang‐Thomsen. (1987). Endocrine therapy of human breast cancer grown in nude mice. Breast Cancer Research and Treatment. 10(3). 229–242. 16 indexed citations
20.
Grønvall, Sven, et al.. (1981). Ultrasound in the detection of testicular tumours. International Journal of Andrology. 4(s4). 185–189. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026